EUVIMEDEUVIMED entdecken
Crossref

TRDMT1-dependent m5C modification of TLR4 mediates the protective effects of Shaoyao decoction in TNBS-induced Crohn's disease

Yonghao Deng, Jing Wang, Mengying Li, Guozhong Xiao, Yajun Pan, Yujie Tao, Min Zhao, Heng Zhang

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2026.117233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Yonghao Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China; Guangdong Provinc…. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Crohn Disease, Drugs, Chinese Herbal, Anti-Inflammatory Agents. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Qinglan Project of Jiangsu Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Crohn's disease (CD) is a chronic inflammatory disease of the digestive system with increasing morbidity worldwide. Shaoyao Decoction (SYD), a traditional Chinese medicine formula, has shown therapeutic potential in the treatment of CD. However, the underlying mechanisms remain unclear. This study aimed to elucidate the molecular mechanisms underlying the protective effects of SYD against 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced CD-like colitis through the tRNA aspartic acid methyltransferase 1 (TRDMT1)/TLR4/NF-κB signaling pathway. EXPERIMENTAL PROCEDURE: We used network pharmacology to identify potential targets and related pathways of SYD in the treatment of CD. The CD model was induced by TNBS. Immunofluorescence, Western blotting, and ELISA were employed to detect various cytokines and proteins associated with epithelial barrier, inflammation, apoptosis, and signaling pathway regulation. TLR4 mRNA expression and the 5-methylcytosine (m5C) modification level of TLR4 mRNA were assayed by qRT-PCR and MeRIP-qPCR. TRDMT1 silencing in Caco2 cells and TLR4 knockout (TLR4-/-) mice were used to verify the mechanism by which SYD attenuated CD symptoms. KEY RESULTS: The TLR4/NF-κB pathway was identified as the core regulatory mechanism. Administration of SYD alleviated TNBS-induced CD-like colitis in mice, as evidenced by the restoration of intestinal mucosal barrier integrity, reduced inflammation, and decreased apoptosis. At the molecular level, SYD reduced the expression of TLR4 and MyD88, suppressed NF-κB phosphorylation and nuclear translocation, and increased TRDMT1 expression. SYD also enhanced the m5C modification level of TLR4 mRNA. Furthermore, mechanistic studies indicated that TRDMT1 and TLR4 were involved in the protective effects of SYD against CD-like colitis. CONCLUSIONS AND IMPLICATIONS: SYD can alleviate intestinal inflammation, inhibit apoptosis, and protect the intestinal barrier in the CD model. This protective effect may be mediated through upregulation of TRDMT1, which enhances the m5C modification of TLR4 mRNA, thereby reducing TLR4 expression and suppressing TLR4/MyD88/NF-κB signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4Crohn DiseaseDrugs, Chinese HerbalAnti-Inflammatory AgentsColitisAnimalsTrinitrobenzenesulfonic AcidHumansSignal TransductionMiceNF-kappa BMaleCaco-2 CellsMice, KnockoutDisease Models, AnimalMice, Inbred C57BLMyeloid Differentiation Factor 88ApoptosisIntestinal Mucosa

Stichwörter der Autor:innen

ApoptosisCrohn’s disease (CD)Shaoyao decoction (SYD)TLR4TRDMT1

Substanzen

Toll-Like Receptor 4Trinitrobenzenesulfonic AcidDrugs, Chinese HerbalNF-kappa BTlr4 protein, mouseAnti-Inflammatory AgentsMyeloid Differentiation Factor 88TLR4 protein, human

Autor:innen und Institutionen

  • Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth…
  • School of Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • School of Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China; Department of Colorectal Surgery, Xuzhou hospital Affiliated to Nanjing University of Chinese Medicine, Xuzhou 221000, China…

Förderung

  • National Natural Science Foundation of China
  • Qinglan Project of Jiangsu Province of China

Zitieren

APA

Deng, Y., Wang, J., Li, M., Xiao, G., Pan, Y., Tao, Y., Zhao, M., & Zhang, H. (2026). TRDMT1-dependent m5C modification of TLR4 mediates the protective effects of Shaoyao decoction in TNBS-induced Crohn's disease. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117233

Vancouver

Deng Y, Wang J, Li M, Xiao G, Pan Y, Tao Y, et al. TRDMT1-dependent m5C modification of TLR4 mediates the protective effects of Shaoyao decoction in TNBS-induced Crohn's disease. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117233

BibTeX
@article{Deng2026,
  author = {Deng, Yonghao and Wang, Jing and Li, Mengying and Xiao, Guozhong and Pan, Yajun and Tao, Yujie and Zhao, Min and Zhang, Heng},
  title = {TRDMT1-dependent m5C modification of TLR4 mediates the protective effects of Shaoyao decoction in TNBS-induced Crohn's disease},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2026.117233}
}
Kostenlos starten →